FSD Pharma (FSD Pharma) Total Stockholders Equity : $13.24 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is FSD Pharma Total Stockholders Equity?

FSD Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $13.24 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. FSD Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was $0.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. FSD Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.03.

FSD Pharma Total Stockholders Equity Historical Data

The historical data trend for FSD Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FSD Pharma Total Stockholders Equity Chart

FSD Pharma Annual Data

Trend

Aug15

Aug16

Aug17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

36.28

36.31

54.13

30.54

13.24

FSD Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															30.54	20.86	15.55	14.84	13.24

FSD Pharma (NAS:HUGE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

FSD Pharma's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(13.237	-	0)	/	39.3768
	=	0.34

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

FSD Pharma's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.339	+	0)	/	13.237
	=	0.03

FSD Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of FSD Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

FSD Pharma (FSD Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FSD Pharma Inc (NAS:HUGE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

0K9:Germany HUGE:Canada

Address

199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9

Website

https://www.fsdpharma.com

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The Company operates in two segments: Biotechnology and Strategic Investments.